We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
Intuitive Surgical (ISRG - Free Report) closed at $506.93 in the latest trading session, marking a -0.88% move from the prior day. This move lagged the S&P 500's daily loss of 0.55%. Elsewhere, the Dow lost 0.5%, while the tech-heavy Nasdaq lost 0.42%.
Heading into today, shares of the robotic surgery system company had lost 10.16% over the past month, lagging the Medical sector's loss of 6.09% and the S&P 500's loss of 5.71% in that time.
Investors will be hoping for strength from ISRG as it approaches its next earnings release, which is expected to be January 24, 2019. In that report, analysts expect ISRG to post earnings of $2.96 per share. This would mark year-over-year growth of 16.54%. Our most recent consensus estimate is calling for quarterly revenue of $1.02 billion, up 14.33% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $10.91 per share and revenue of $3.70 billion. These totals would mark changes of +21.36% and +18.23%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for ISRG. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.36% higher within the past month. ISRG currently has a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that ISRG has a Forward P/E ratio of 46.88 right now. For comparison, its industry has an average Forward P/E of 32.37, which means ISRG is trading at a premium to the group.
Also, we should mention that ISRG has a PEG ratio of 3. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments industry currently had an average PEG ratio of 2.73 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 89, which puts it in the top 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know
Intuitive Surgical (ISRG - Free Report) closed at $506.93 in the latest trading session, marking a -0.88% move from the prior day. This move lagged the S&P 500's daily loss of 0.55%. Elsewhere, the Dow lost 0.5%, while the tech-heavy Nasdaq lost 0.42%.
Heading into today, shares of the robotic surgery system company had lost 10.16% over the past month, lagging the Medical sector's loss of 6.09% and the S&P 500's loss of 5.71% in that time.
Investors will be hoping for strength from ISRG as it approaches its next earnings release, which is expected to be January 24, 2019. In that report, analysts expect ISRG to post earnings of $2.96 per share. This would mark year-over-year growth of 16.54%. Our most recent consensus estimate is calling for quarterly revenue of $1.02 billion, up 14.33% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $10.91 per share and revenue of $3.70 billion. These totals would mark changes of +21.36% and +18.23%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for ISRG. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.36% higher within the past month. ISRG currently has a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that ISRG has a Forward P/E ratio of 46.88 right now. For comparison, its industry has an average Forward P/E of 32.37, which means ISRG is trading at a premium to the group.
Also, we should mention that ISRG has a PEG ratio of 3. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments industry currently had an average PEG ratio of 2.73 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 89, which puts it in the top 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.